Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009009776 - PATIENT SELECTION AND THERAPEUTIC METHODS USING MARKERS OF PROSTAGLANDIN METABOLISM

Publication Number WO/2009/009776
Publication Date 15.01.2009
International Application No. PCT/US2008/069892
International Filing Date 11.07.2008
IPC
A01N 43/36 2006.01
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
34having rings with one nitrogen atom as the only ring hetero atom
36five-membered rings
A61K 31/40 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
CPC
A61K 31/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
G01N 2333/90216
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
90Enzymes; Proenzymes
902Oxidoreductases (1.)
90216acting on a heme group of donors (1.9)
G01N 2500/00
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2500Screening for compounds of potential therapeutic value
G01N 2800/52
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
52Predicting or monitoring the response to treatment; Prognosis
Applicants
  • TRAGARA PHARMACEUTICALS, INC. [US]/[US] (AllExceptUS)
  • LAWHON, Tracy [US]/[US] (UsOnly)
  • ZAKNOEN, Sara [US]/[US] (UsOnly)
  • ESTOK, Thomas [US]/[US] (UsOnly)
  • GREEN, Mark [US]/[US] (UsOnly)
Inventors
  • LAWHON, Tracy
  • ZAKNOEN, Sara
  • ESTOK, Thomas
  • GREEN, Mark
Agents
  • ELAMRANI, Samir PhD., Esq.
Priority Data
60/949,47312.07.2007US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PATIENT SELECTION AND THERAPEUTIC METHODS USING MARKERS OF PROSTAGLANDIN METABOLISM
(FR) SÉLECTION DE PATIENT ET PROCÉDÉS THÉRAPEUTIQUES UTILISANT DES MARQUEURS DU MÉTABOLISME DE LA PROSTAGLANDINE
Abstract
(EN)
Disclosed herein are methods related generally to a patient selection process for identifying individuals for treatment of cancer, inflammation, pain, and/or related conditions.
(FR)
La présente invention concerne des procédés liés d'une manière générale à un processus de sélection de patient. Ledit processus est destiné à identifier des individus en vue de traiter un cancer, des inflammations, une douleur et/ou des pathologies afférentes.
Also published as
Latest bibliographic data on file with the International Bureau